HR-2706 : Still Just a Bill

Freedom from Price Gouging Act

This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.

Action Timeline

Action DateTypeTextSource
2021-04-21CommitteeReferred to the Subcommittee on Health.House committee actions
2021-04-20CommitteeReferred to the Subcommittee on Social Security.House committee actions
2021-04-20CommitteeReferred to the Subcommittee on Health.House committee actions
2021-04-20IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2021-04-20IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2021-04-20IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Health
See Subjects
  • Civil actions and liability
  • Congressional oversight
  • Government studies and investigations
  • Health care costs and insurance
  • Inflation and prices
  • Medicare
  • Prescription drugs

Related Bills

See Related Bills